Kathleen Börner
Kathleen Börner
Research scientist
Verified email at
Cited by
Cited by
A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples
VL Dao Thi, K Herbst, K Boerner, M Meurer, LPM Kremer, D Kirrmaier, ...
Science translational medicine 12 (556), eabc7075, 2020
CRISPR/Cas9‐mediated genome engineering: an adeno‐associated viral (AAV) vector toolbox
E Senís, C Fatouros, S Große, E Wiedtke, D Niopek, AK Mueller, K Börner, ...
Biotechnology journal 9 (11), 1402-1412, 2014
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver
D Grimm, L Wang, JS Lee, N Schürmann, S Gu, K Börner, TA Storm, ...
The Journal of clinical investigation 120 (9), 3106-3119, 2010
Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments
S Fanucchi, ET Fok, E Dalla, Y Shibayama, K Börner, EY Chang, ...
Nature genetics 51 (1), 138-150, 2019
Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9
F Bubeck, MD Hoffmann, Z Harteveld, S Aschenbrenner, A Bietz, ...
Nature methods 15 (11), 924-927, 2018
Cone-shaped HIV-1 capsids are transported through intact nuclear pores
V Zila, E Margiotta, B Turoňová, TG Müller, CE Zimmerli, S Mattei, ...
Cell 184 (4), 1032-1046. e18, 2021
HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex
DA Bejarano, K Peng, V Laketa, K Börner, KL Jost, B Lucic, B Glass, ...
Elife 8, e41800, 2019
SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP
S Klein, TG Müller, D Khalid, V Sonntag-Buck, AM Heuser, B Glass, ...
Viruses 12 (8), 863, 2020
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
MD Hoffmann, S Aschenbrenner, S Grosse, K Rapti, C Domenger, ...
Nucleic acids research 47 (13), e75-e75, 2019
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines
K Börner, D Niopek, G Cotugno, M Kaldenbach, T Pankert, J Willemsen, ...
Nucleic acids research 41 (21), e199-e199, 2013
Type I interferon regulates the expression of long non-coding RNAs
E Carnero, M Barriocanal, V Segura, E Guruceaga, C Prior, K Börner, ...
Frontiers in immunology 5, 548, 2014
Relevance of assembly-activating protein for adeno-associated virus vector production and capsid protein stability in mammalian and insect cells
S Grosse, M Penaud-Budloo, AK Herrmann, K Börner, J Fakhiri, V Laketa, ...
Journal of virology 91 (20), e01198-17, 2017
Synthetic AAV/CRISPR vectors for blocking HIV‐1 expression in persistently infected astrocytes
C Kunze, K Börner, E Kienle, T Orschmann, E Rusha, M Schneider, ...
Glia 66 (2), 413-427, 2018
Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice
S Beer, DI Bellovin, JS Lee, K Komatsubara, LS Wang, H Koh, K Börner, ...
Molecular Therapy 18 (1), 161-170, 2010
From experimental setup to bioinformatics: An RNAi screening platform to identify host factors involved in HIV‐1 replication
K Börner, J Hermle, C Sommer, NP Brown, B Knapp, B Glass, J Kunkel, ...
Biotechnology Journal: Healthcare Nutrition Technology 5 (1), 39-49, 2010
Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling
E Kienle, E Senís, K Börner, D Niopek, E Wiedtke, S Grosse, D Grimm
JoVE (Journal of Visualized Experiments), e3819, 2012
Pre-arrayed pan-AAV peptide display libraries for rapid single-round screening
K Börner, E Kienle, LY Huang, J Weinmann, A Sacher, P Bayer, C Stüllein, ...
Molecular therapy 28 (4), 1016-1032, 2020
Proteome analysis of the HIV-1 Gag interactome
CE Engeland, NP Brown, K Börner, M Schümann, E Krause, L Kaderali, ...
Virology 460, 194-206, 2014
Nanobody-enhanced targeting of AAV gene therapy vectors
AM Eichhoff, K Börner, B Albrecht, W Schäfer, N Baum, F Haag, J Körbelin, ...
Molecular Therapy-Methods & Clinical Development 15, 211-220, 2019
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two …
A Deckert, S Anders, M De Allegri, HT Nguyen, A Souares, S McMahon, ...
Trials 22, 1-9, 2021
The system can't perform the operation now. Try again later.
Articles 1–20